IMNM
Price
$17.51
Change
-$0.18 (-1.02%)
Updated
Nov 20 closing price
Capitalization
1.61B
118 days until earnings call
Intraday BUY SELL Signals
LRMR
Price
$3.37
Change
-$0.10 (-2.88%)
Updated
Nov 20 closing price
Capitalization
288.44M
117 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMNM vs LRMR

Header iconIMNM vs LRMR Comparison
Open Charts IMNM vs LRMRBanner chart's image
Immunome
Price$17.51
Change-$0.18 (-1.02%)
Volume$850.41K
Capitalization1.61B
Larimar Therapeutics
Price$3.37
Change-$0.10 (-2.88%)
Volume$1.34M
Capitalization288.44M
IMNM vs LRMR Comparison Chart in %
IMNM
Daily Signal:
Gain/Loss:
LRMR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMNM vs. LRMR commentary
Nov 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and LRMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 21, 2025
Stock price -- (IMNM: $17.51 vs. LRMR: $3.37)
Brand notoriety: IMNM and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 54% vs. LRMR: 44%
Market capitalization -- IMNM: $1.61B vs. LRMR: $288.44M
IMNM [@Biotechnology] is valued at $1.61B. LRMR’s [@Biotechnology] market capitalization is $288.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMNM and LRMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 3 TA indicator(s) are bullish while LRMR’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 3 bullish, 5 bearish.
  • LRMR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LRMR is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а +6.06% price change this week, while LRMR (@Biotechnology) price change was +2.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.65%. For the same industry, the average monthly price growth was -7.08%, and the average quarterly price growth was +60.39%.

Reported Earning Dates

IMNM is expected to report earnings on Mar 19, 2026.

LRMR is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (-1.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($1.61B) has a higher market cap than LRMR($288M). IMNM YTD gains are higher at: 64.878 vs. LRMR (-12.920). LRMR has higher annual earnings (EBITDA): -108.21M vs. IMNM (-187.92M). IMNM has more cash in the bank: 268M vs. LRMR (139M). IMNM has less debt than LRMR: IMNM (4.14M) vs LRMR (4.61M). IMNM has higher revenues than LRMR: IMNM (12.6M) vs LRMR (0).
IMNMLRMRIMNM / LRMR
Capitalization1.61B288M558%
EBITDA-187.92M-108.21M174%
Gain YTD64.878-12.920-502%
P/E RatioN/AN/A-
Revenue12.6M0-
Total Cash268M139M193%
Total Debt4.14M4.61M90%
FUNDAMENTALS RATINGS
LRMR: Fundamental Ratings
LRMR
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMLRMR
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signal:
Gain/Loss:
LRMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNPQY39.871.15
+2.98%
BNP Paribas
BSDGY31.08N/A
N/A
Bosideng International Holdings Ltd.
CSBB49.00N/A
N/A
CSB Bancorp, Inc.
TCNB6.05N/A
N/A
Town Center Bank (IL)
LYPHF0.39N/A
N/A
Luye Pharma Group LTD.

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-1.02%
IDYA - IMNM
57%
Loosely correlated
+0.09%
IPSC - IMNM
54%
Loosely correlated
-4.42%
RLAY - IMNM
53%
Loosely correlated
+0.63%
NRIX - IMNM
52%
Loosely correlated
+6.98%
SYRE - IMNM
52%
Loosely correlated
-3.42%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with OCUL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-2.88%
OCUL - LRMR
43%
Loosely correlated
-3.18%
MLTX - LRMR
43%
Loosely correlated
-3.99%
ERAS - LRMR
42%
Loosely correlated
+0.91%
EYPT - LRMR
41%
Loosely correlated
-4.34%
IMNM - LRMR
41%
Loosely correlated
-1.02%
More